Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 8.63
0.00 (0.00%)
Sep 17, 2026, 4:10 PM EST
Devonian Health Group Market Cap
Devonian Health Group has a market cap or net worth of CAD 23.98 million as of September 18, 2026. Its market cap has decreased by -13.96% in one year.
Market Cap
23.98M
Enterprise Value
23.41M
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.63
ChartMarket Cap Chart
Since May 19, 2017, Devonian Health Group's market cap has decreased from 1.44B to 23.98M, a decrease of -98.34%. That is a compound annual growth rate of -35.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 23.98M | -23.93% |
| Dec 24, 2025 | 31.53M | 32.95% |
| Dec 30, 2024 | 23.72M | 11.47% |
| Dec 21, 2023 | 21.28M | -52.33% |
| Dec 21, 2022 | 44.63M | -94.11% |
| Dec 31, 2021 | 758.36M | 359.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 39.23M |
| Telescope Innovations | 37.18M |
| Defence Therapeutics | 37.14M |
| Thiogenesis Therapeutics | 35.69M |
| Resverlogix | 30.99M |
| The More Life Company | 29.71M |
| Pharmala Biotech Holdings | 29.07M |
| Onco-Innovations | 27.32M |